Evidence map›Paper›PMID 36638335›Full record

ArticleBlood2023

Prior immunization against an intracellular antigen enhances subsequent red blood cell alloimmunization in mice.

Ryan Jajosky, Seema R Patel, Shang-Chuen Wu, Kashyap Patel, Mischa Covington, Mary Vallecillo-Zúniga, Diyoly Ayona, Ashley Bennett, C John Luckey, Krystalyn E Hudson and 6 more

Open access · greenAbstract read
In one paragraph

Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Analysis of Erythrocyte Membrane Alloantigens.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. Acute Incompatible Red Blood Cell Transfusion in Mice.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Anemia and Transfusion in Preclinical Models of Neonatology.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  6. Flow Cytometric Examination of Galectin Binding to Red Blood Cells.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  7. Article
  8. Use of Microbial Microarrays to Define Antibody Specificity.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  9. Expression and Characterization of Blood Group Binding Lectins.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  10. Analysis of Galectin Binding to Blood Group Expressing Bacteria.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  11. Article
  12. Mouse Model of Hemolytic Disease of the Fetus and Newborn.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  13. The Immunology of Transfusion Medicine: Past, Present, and Future.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  14. Analysis of Biotinylated Red Blood Cells Following Transfusion.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  15. Murine Models of Transfusion-Induced Red Blood Cell Alloimmunization.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  16. Article
  17. Article
  18. Research progress in RBC alloimmunization.Frontiers in immunology · 2025
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Ryan JajoskyJoint Program in Transfusion Medicine, Brigham and Women's Hospital, National Center for Functional Glycomics, Harvard School of Medicine, Boston, MA.ORCID 0000-0001-8458-7635
Seema R PatelAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA.
Shang-Chuen WuJoint Program in Transfusion Medicine, Brigham and Women's Hospital, National Center for Functional Glycomics, Harvard School of Medicine, Boston, MA.ORCID 0000-0002-5284-5596
Kashyap PatelJoint Program in Transfusion Medicine, Brigham and Women's Hospital, National Center for Functional Glycomics, Harvard School of Medicine, Boston, MA.
Mischa CovingtonJoint Program in Transfusion Medicine, Brigham and Women's Hospital, National Center for Functional Glycomics, Harvard School of Medicine, Boston, MA.ORCID 0000-0001-5452-4529
Mary Vallecillo-ZúnigaJoint Program in Transfusion Medicine, Brigham and Women's Hospital, National Center for Functional Glycomics, Harvard School of Medicine, Boston, MA.ORCID 0000-0001-7662-4010
Diyoly AyonaJoint Program in Transfusion Medicine, Brigham and Women's Hospital, National Center for Functional Glycomics, Harvard School of Medicine, Boston, MA.ORCID 0000-0002-4874-3706
Ashley BennettDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0002-3256-2935
C John LuckeyDepartment of Pathology, University of Virginia, Charlottesville, VA.ORCID 0000-0002-0787-9121
Krystalyn E HudsonDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York City, NY.
Jeanne E HendricksonDepartment of Laboratory Medicine, Yale School of Medicine, New Haven, CT.ORCID 0000-0002-7928-3132
Stephanie C EisenbarthCenter for Human Immunology, Department of Medicine, Northwestern University School of Medicine, Chicago, IL.
Cassandra D JosephsonCancer and Blood Disorders Institute and Blood Bank/Transfusion Medicine Division, Johns Hopkins All Children's Hospital, St. Petersburg, FL.
Patricia E ZerraCenter for Transfusion Medicine and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0003-3675-2725
Sean R StowellJoint Program in Transfusion Medicine, Brigham and Women's Hospital, National Center for Functional Glycomics, Harvard School of Medicine, Boston, MA.ORCID 0000-0002-1130-9551
Connie M ArthurJoint Program in Transfusion Medicine, Brigham and Women's Hospital, National Center for Functional Glycomics, Harvard School of Medicine, Boston, MA.ORCID 0009-0006-9246-7231
Brigham and Women's Hospital · USEmory University · USColumbia University Irving Medical Center · USJohns Hopkins University · USNorthwestern University · USUniversity of Virginia · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
TRANSFUSION BIOLOGY AND MEDICINET32HL066987 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI JOHN P MANIS · 2001 to 2026
$10.2M
Forging Translational Glycobiologists: Intermeshing Glycoscience Training and Clinical EducationK12HL141953 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHAIKOF, ELLIOT, CUMMINGS, RICHARD D · 2018 to 2022
$4.8M
Examination of Initiating Factors that Regulate Red Blood Cell AlloimmunizationR01HL135575 · NHLBI · EMORY UNIVERSITY · PI Sean R Stowell · 2017 to 2026
$2.8M
Examining Immune Circuits Responsible for Anamnestic RBC AlloimmunizationR01HL165975 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI STOWELL, SEAN R · 2022 to 2025
$2.4M
Examining the Mechanisms of RBC Alloimmunization HyperrespondersR01HL154034 · NHLBI · EMORY UNIVERSITY · PI ARTHUR, CONNIE M · 2020 to 2024
$2.1M
Responsiveness and non-responsiveness to transfused RBCs in mice and humans.R01HL132951 · NHLBI · YALE UNIVERSITY · PI GALLAGHER, PATRICK G · 2017 to 2020
$1.7M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS K12 HL141953NHLBI NIH HHS R01 HL132951NHLBI NIH HHS R01 HL135575NHLBI NIH HHS R01 HL154034NHLBI NIH HHS R01 HL165975NHLBI NIH HHS T32 HL066987
6 · The paper itself

Abstract

Antibodies against red blood cell (RBC) alloantigens can increase morbidity and mortality among transfusion recipients. However, alloimmunization rates can vary dramatically, as some patients never generate alloantibodies after transfusion, whereas others not only become alloimmunized but may also be prone to generating additional alloantibodies after subsequent transfusion. Previous studies suggested that CD4 T-cell responses that drive alloantibody formation recognize the same alloantigen engaged by B cells. However, because RBCs express numerous antigens, both internally and externally, it is possible that CD4 T-cell responses directed against intracellular antigens may facilitate subsequent alloimmunization against a surface RBC antigen. Here, we show that B cells can acquire intracellular antigens from RBCs. Using a mouse model of donor RBCs expressing 2 distinct alloantigens, we demonstrate that immune priming to an intracellular antigen, which would not be detected by any currently used RBC compatibility assays, can directly influence alloantibody formation after exposure to a subsequent distinct surface RBC alloantigen. These findings suggest a previously underappreciated mechanism whereby transfusion recipient responders may exhibit an increased rate of alloimmunization because of prior immune priming toward intracellular antigens.

Indexed as

Erythrocyte TransfusionIsoantibodiesAntigensErythrocytesImmunizationIsoantigensAntigensIsoantibodiesIsoantigens

Identifiers

PMID36638335
PMCPMC10356576
OpenAlexW4316014099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.